From: Increased levels of a pro-inflammatory IgG receptor in the midbrain of people with schizophrenia
Demographics | DAB immunohistochemistry cohort | ||
---|---|---|---|
Control | Schizophrenia | Statistics | |
n | 28 | 30 | – |
Age (years) | 52.5 (22–69) | 54.5 (26–67) | t(56) = − 0.27, p = 0.78 |
Sex (M, F) | 18,10 | 19,11 | X2 = 0.006, p = 0.94 |
pH | 6.6 ± 0.28 (5.8–7.0) | 6.4 ± 0.23 (5.8–6.8) | t(56) = 2.56 p = 0.01** |
PMI (h) | 32.8 ± 9.7 (15–50) | 36.2 ± 17.7 (5–72) | t(45.5) = − 0.90, p = 0.37 |
RIN | 5.4 ± 1.2 (2.6–7.3) | 5.4 ± 1.4 (2.7–8.3) | t(56) = 0.14, p = 0.98 |
Age at illness onset (years) | – | 22.2 ± 7.2 (15–46) | – |
Duration of illness (years) | – | 29.6 ± 12.7 (4–49) | – |
Daily CPZ equivalent dose (mg)a | – | 736.5 ± 520.5 (200–2363) | – |
Last recorded CPZ equivalent dose (mg)b | – | 630.7 ± 520.3 (20–1732) | – |